Moody’s Analytics Expands its Award-Winning Data Alliance
Moody’s Analytics, a global provider of financial intelligence, has expanded the Data Alliance so that members can now securely upload data for all accepted asset classes and all regions through the Data Alliance Portal (“the Portal”).
It is now more convenient and more secure for Data Alliance members to contribute data and collect credit risk benchmarking insights in return. The Data Alliance’s global database continues to grow and now includes 100 million Commercial & Industrial (C&I) private firm financial statements, $398 billion in Commercial Real Estate (CRE) loan balances covering 354 MSAs, and 63% of all Project Finance loans originated since 1983.
Protecting the confidentiality of member data is paramount. With all data submissions now made exclusively through the Portal, we have strengthened the program’s data security.
“Our members look to the Data Alliance for meaningful insight into their portfolio risk,” said Jean Liu, Senior Director at Moody’s Analytics. “Being able to use the Portal for all their submissions makes getting those insights faster, easier, and more secure.”
Adding to our CRE release earlier this year, Project Finance, Asset Finance, C&I, and Agriculture are among the asset classes for which members can now contribute data and receive insight through the Portal. The Data Alliance also continues to expand globally, including a focus on European CRE and African C&I.
“We’re pleased that Data Alliance members can now contribute data and collect insight for all Portal asset classes,” said Doug Johnson, Director at Moody’s Analytics. “In particular, agricultural lenders will welcome the availability of agriculture lending data and best practices.”
We are also continually looking at other Moody’s Analytics solutions for ways to enhance the Data Alliance. For example, a recent initiative to deepen portfolio analysis builds on our RiskFrontier™ solution and gives Data Alliance members and clients of the RiskFrontier solution the ability to compare their lending profile to peer group benchmarks for economic capital and profitability.
The Data Alliance earned Moody’s Analytics the award for Credit Data Provider of the Year in the 2018 Risk Technology Awards. This win added to the growing list of awards for Moody’s Analytics, including Technology Vendor of the Year in the 2018 Risk Awards.
Click here to contact the Data Alliance team for more information including the exclusive benefits of being a member.
About Moody’s Analytics
Moody’s Analytics provides financial intelligence and analytical tools to help business leaders make better, faster decisions. Our deep risk expertise, expansive information resources, and innovative application of technology help our clients confidently navigate an evolving marketplace. We are known for our industry-leading and award-winning solutions, made up of research, data, software, and professional services, assembled to deliver a seamless customer experience. We create confidence in thousands of organizations worldwide, with our commitment to excellence, open mindset approach, and focus on meeting customer needs. For more information about Moody’s Analytics, visit www.moodysanalytics.com.
Moody's Analytics is a subsidiary of Moody's Corporation (NYSE:MCO). MCO reported revenue of $4.2 billion in 2017, employs approximately 12,600 people worldwide and maintains a presence in 42 countries.
Moody’s Analytics Communications
Justin Bursztein, +1-212-553-1163
Moody’s Analytics Media Relations
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zyxel Launches 5G NR Fixed Wireless Access Portfolio26.5.2020 09:00:00 EEST | Press release
Zyxel Communications announced its 5G Fixed Wireless Access (FWA) product portfolio is available for service providers and mass production will begin as soon as Q2 2020. To accelerate your business with Zyxel 5G NR FWA, click here. Today’s subscribers expect robust bandwidth and low latency. Some households, however, are limited in terms of reliable broadband connections. The Zyxel FWA portfolio helps service providers leverage 5G NR technology to deliver high-capacity, premium broadband services, high-speed connectivity, enhanced network security, and deployment flexibility. With outdoor, indoor, and portable options, Zyxel offers a wide range of products with its 5G NR FWA portfolio, including: · 5G NR Outdoor Router (NR7101) · 5G NR Indoor Router (NR5101) · 5G NR Portable Router (NR2101) Together, these solutions ensure connectivity everywhere. Combining the latest in WiFi 6 technology, Zyxel’s 5G NR solution portfolio creates a superior, ultra-high speed and zero-dead-zone WiFi exp
Kyoto Semiconductor Announces a Photodiode in the Industry’s Smallest Class, with a Broad Range of Sensitivity Wavelengths, from 400 to 1,700 nm26.5.2020 08:00:00 EEST | Press release
In the forty years since the company’s founding, Kyoto Semiconductor Co., Ltd., Tsuneo Takahashi, President and CEO, and headquartered in Fushimi Ward, Kyoto, has led the industry with optical solutions built from world-standard technologies and with Japanese quality and attention to production detail. They have announced the development of a Two-Wavelength Photodiode, the KP-2 Two-tone Photodiode KPMC29, in the industry’s smallest class and capable of being surface-mounted, with silicon and indium-gallium-arsenide photodiodes, with photosensitivity for a wide range of wavelengths, from 400 to 1,700 nm, arrayed along the same light axis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200525005017/en/ Kyoto Semiconductor KP-2 Two-tone Photodiode KPMC29 (Photo: Business Wire) This broadband sensitivity, together with a smaller package that is 1/8 the volume ratio of older Kyoto Semiconductor products, can be used in the health
Novaremed Announces IND Submitted to U.S. FDA for Phase 2 Study of NRD135S.E1 for the Treatment of Painful Diabetic Peripheral Neuropathy; Also Announces the Appointment of Three New Board Members25.5.2020 19:30:00 EEST | Press release
Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for the novel drug candidate (NRD135S.E1) for the treatment of Painful Diabetic Peripheral Neuropathy (PDPN) to evaluate NRD135S.E1 in a Phase 2 study. Novaremed had received initial feedback from the FDA during a Pre-IND meeting held on July 24, 2019. The Phase 2 study, designed as a randomized, double-blind, placebo-controlled study, will enroll patients experiencing neuropathic pain caused by Diabetes Mellitus. Eligible patients will be randomized to receive oral doses of either NRD135S.E1 or placebo once daily for 3 months. “Submitting this IND is an important next step in the clinical development of NRD135S.E1 for the treatment of PDPN and we are moving rapidly to potentially address a global unmet medical need,” said Sara Mangialaio, M.D., Ph.D., CMO and Head of R&D at Novarem
Closer Collaboration between the EUIPO and EURid to Benefit SMEs25.5.2020 14:30:00 EEST | Press release
The European Union Intellectual Property Office (EUIPO) and EURid, the domain name registry for the .eu, .ею and .ευ top-level domains, are set to intensify collaboration to support trade mark and domain name applicants and owners, particularly small and medium enterprises (SMEs). This collaboration will support users of the EU IP system, particularly startups, by helping them to obtain trade mark and domain name protection in a joined-up manner, so they can secure their brands from the very beginning of their business journey. At present, EU trade mark applicants are advised whether their trade mark is available as a .eu domain name at the end of the online application process at EUIPO. Applicants and holders can also set up alerts to be informed once a .eu domain name that matches their trade mark is registered. Under a new work programme agreed jointly by the two organisations, the EUIPO and EURid will explore the possibility of implementing a reciprocal process when a .eu domain na
TIP Trailer Services Announces Appointment of New CFO25.5.2020 11:05:00 EEST | Press release
TIP Trailer Services, a portfolio company of I Squared Capital, has appointed Hans van Lierop as Chief Financial Officer and management board member. Hans started as CFO for TIP from Monday, 18th of May 2020 and is based in TIP’s international headquarters in Amsterdam, the Netherlands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200525005042/en/ Hans van Lierop, appointed CFO of TIP Trailer Services (Photo: Business Wire) “I am looking forward to joining TIP’s senior leadership team and leading its Finance organisation and look forward to contributing to TIPs future success. ” Hans van Lierop commented. Hans van Lierop joins TIP with broad international experience from different industries in Europe and Africa. He has held financial leadership roles in Diageo, Airtel and Massmart Walmart. Most recently, Hans Van Lierop was CFO of Massmart Walmart, a South African retail and wholesale distributor with a turnover of US$ 7
Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Populations with Difficult-to-Treat Migraine25.5.2020 09:00:00 EEST | Press release
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) presented a wide range of important new data on AJOVY® (fremanezumab) and the societal and economic impact of migraine in Europe at the 6th Congress of the European Academy of Neurology (EAN). This year’s EAN congress was a virtual meeting due to the global coronavirus pandemic. The fremanezumab data included pooled analyses of the AJOVY Phase 3 clinical trials (FOCUS, HALO-episodic migraine (EM) and HALO-chronic migraine (CM)) which focused on the safety, efficacy and improved quality-of-life for patients experiencing difficult-to-treat migraine. Post-hoc analyses were also evaluated in patients who may experience challenges when managing their migraine due to comorbidities. Migraine creates a significant disease and economic burden. With more than one billion people impacted globallyi, migraine is the second leading global cause of years lived with disabilityii and annual costs of the disease in the U.S. and EU are $200 billio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom